# US 2010/0168808 A1 · Preventing biofilm formation on implantable medical devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168808 A1
- Document ID: US20100168808A1
- Status: Published application
- Kind: A1
- Application number: 12/648,126
- Filed: 2009-12-28
- Published: 2010-07-01
- Earliest claimed: 2006-02-08
- Assignees: TYRX, Inc.
- Inventors: Mark CITRON
- Web page: https://patentgrep.com/patent/US20100168808A1

## CPC

- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61L 31/10: Macromolecular materials
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- A61L 31/148: {Materials at least partially resorbable by the body}
- A61B 2017/00889: {antimicrobial, disinfectant}
- A61B 2017/00893: {pharmaceutically effective}
- A61B 2090/0815: {Implantable devices for insertion in between organs or other soft tissues}
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61N 1/375: Constructional arrangements, e.g. casings
- A61N 1/37512: {Pacemakers}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Biodegradable polymer-coated surgical meshes formed into pouches are described for use with cardiac rhythm management devices (CRMs) and other implantable medical devices. Such meshes are formed into a receptacle, e.g., a pouch or other covering, capable of encasing, surrounding and/or holding the cardiac rhythm management device or other implantable medical device and preventing or retarding the formation of a biofilm.

## Claims

### Claim 1

A method of preventing or retarding biofilm formation on an implantable medical device which comprises:
(a) enveloping or covering said device, in whole or in part, in a polymer pouch comprising one or more antimicrobial agents in amounts effective to prevent or retard biofilm formation; and
(b) implanting said enveloped device in a subject.

### Claim 2 (depends on 1)

The method of claim 1, wherein the polymer pouch is a polymer-coated mesh pouch.

### Claim 3 (depends on 2)

The method of claim 2, wherein the polymer-coated mesh pouch comprises a one or more resorbable polymers coated on a mesh.

### Claim 4 (depends on 1)

The method of claim 1, wherein the polymer pouch consists essentially of one or more one resorbable polymers and one or more antimicrobial agents coated onto a mesh.

### Claim 5 (depends on 1)

The method of claim 1, wherein the one or more antimicrobial agents prevent or inhibit biofilm formation by one or more of Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli or Acinetobacter baummanii.

### Claim 6 (depends on 3)

The method of claim 3, wherein the one or more antimicrobial agents prevent or inhibit biofilm formation by one or more of Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli or Acinetobacter baummanii.

### Claim 7 (depends on 1)

The method of claim 1, wherein said implantable medical device is a cardiac rhythm management device (CRMD), a neurostimulator, a pulse generator, a drug pump or infusion device, a physiological monitoring device, or a textured or smooth breast implant.

### Claim 8 (depends on 7)

The method of claim 7, wherein the implantable medical device is a CRMD selected from the group consisting of a pacemaker, a defibrillator, an implantable cardioverter defibrillator (ICD), and a cardiac resynchronization therapy defibrillator (CRT device).

### Claim 9 (depends on 2)

The method of claim 2, wherein said coating comprises two or more layers, and at least one layer of the coating comprises at least one antimicrobial agent and at least one biocompatible polymer.

### Claim 10 (depends on 1)

The method of claim 1, wherein the at least one antimicrobial agent comprises rifampin and minocycline.

### Claim 11 (depends on 3)

The method of claim 3, wherein the at least one antimicrobial agent comprises rifampin and minocycline.

### Claim 12 (depends on 11)

The method of claim 11, wherein the amounts of rifampin and minocyline in the coating ranges from about 60-90 μg/cm2 for each of rifampin and minocycline.

### Claim 13 (depends on 12)

The method of claim 12, wherein the coating comprises about 0.5-1.0 mg resorbable polymer/cm2.

### Claim 14 (depends on 11)

The method of claim 11, wherein the one or more resorbable polymers comprises a DTE-27.5% DT succinate polyarylate.

### Claim 15 (depends on 13)

The method of claim 13, wherein the resorbable polymer is DTE-27.5% DT succinate polyarylate.
